EMCEPH

This brand name is authorized in Nigeria.

Active ingredients

The drug EMCEPH contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 75J73V1629 - CEFTRIAXONE
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5319	Injection	EMCEPH INJECTION INJ 1 g 1Vial + 10ml SWFI	85 CMS-PP-275015 EMCEPH INJECTION CEFTRIAXONE CEFTRIAXONE FOR INJECTION USP 1.0g A4-5319 Drugs Imported Products 1Vial + 10ml SWFI Prescription Only Medicine (POM) 7/27/2022 EMCURE NIGERIA LIMITED, 29 ADENIYI JONES AVENUE, IKEJA LAGOS 8037749701 emcurenigerialtd@gmail.com AQUA VITOE LABORATORIES, PLOT NO. 4, VILLAGE- KUNJHAL, NEAR JHARMAJRI, BADDI, DISTRICT- SOLAN, HIMACHAL PRADESH- 173205, INDIA, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-5319